▶ 調査レポート

アトロピンの世界市場レポート2020

• 英文タイトル:Global Atropine Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。アトロピンの世界市場レポート2020 / Global Atropine Sales Market Report 2020 / 20QY06-00659資料のイメージです。• レポートコード:20QY06-00659
• 出版社/出版日:QYResearch / 2020年6月3日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、140ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥592,000 (USD4,000)▷ お問い合わせ
  Multi User¥888,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,184,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、アトロピンのグローバル市場について種類別(注射、ドロップ、ジェル)、用途別(消化器、眼科、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・アトロピン市場の概要
・世界の主要地域別アトロピン市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界のアトロピン市場規模2015-2026:種類別(注射、ドロップ、ジェル)
・世界のアトロピン市場規模2015-2026:用途別(消化器、眼科、その他)
・アトロピンの北米市場規模2015-2020
・アトロピンのヨーロッパ市場規模2015-2020
・アトロピンの中国市場規模2015-2020
・アトロピンの日本市場規模2015-2020
・アトロピンの東南アジア市場規模2015-2020
・アトロピンのインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(C²PHARMA、RESONANCE LABORATORIES、ROLABO OUTSOURCING、Minsheng、CR Double-Crane、HENAN PURUI、Albany Molecular Research、Alchem International、SAURAV CHEMICALS、Katsura Chemical、Hangzhou Vega、Wuhan senwayer century)
・アトロピンの製造コスト分析
・販売チャネル、流通業者、顧客
・アトロピンの市場動向・機会・課題
・調査の結論

Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.
Atropine is a medication to treat certain types of nerve agent and pesticide poisonings as well as some types of slow heart rate and to decrease saliva production during surgery. It is typically given intravenously or by injection into a muscle. Eye drops are also available which are used to treat uveitis and early amblyopia. The intravenous solution usually begins working within a minute and lasts half an hour to an hour. Large doses may be required to treat some poisonings.

Atropine industry is relatively fragmented, manufacturers are mostly in the North America, Europe and Asia, and China market production volume accounted for more than 25.43% of the total production volume of global Atropine in 2017. C²PHARMA is the world leading manufacturer in global Atropine market with the market share of 9.19%, in terms of revenue, followed by RESONANCE LABORATORIES, ROLABO OUTSOURCING, Minsheng and CR Double-Crane.
As for the volume segment, global Atropine production decreased to 3862.8 Kg from 4247.4 Kg in 2013. Due to low prices, small profit margins and a relatively narrow market, many companies have abandoned production of atropine, and a shortage of atropine has appeared in the market. This is the result of long-term effects of market behavior.

The average price of Atropine will fall further. The product average price declined in the past few years due to its cheap drug properties, and the average price will keep this trend in the few future years due to market vicious circle.

Market Analysis and Insights: Global Atropine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Atropine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Atropine industry.
Based on our recent survey, we have several different scenarios about the Atropine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 530.2 million in 2019. The market size of Atropine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

Global Atropine Scope and Market Size
The global Atropine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Atropine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Atropine market is segmented into
Injection
Drop
Gel

Segment by Application, the Atropine market is segmented into
Gastrointestinal
Ophthalmology
Other

The Atropine market is analysed and market size information is provided by regions (countries). Segment by Application, the Atropine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Atropine Market Share Analysis
Atropine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Atropine business, the date to enter into the Atropine market, Atropine product introduction, recent developments, etc.

The major vendors covered:
C²PHARMA
RESONANCE LABORATORIES
ROLABO OUTSOURCING
Minsheng
CR Double-Crane
HENAN PURUI
Albany Molecular Research
Alchem International
SAURAV CHEMICALS
Katsura Chemical
Hangzhou Vega
Wuhan senwayer century

レポート目次

1 Atropine Market Overview
1.1 Atropine Product Scope
1.2 Atropine Segment by Type
1.2.1 Global Atropine Sales by Type (2020-2026)
1.2.2 Injection
1.2.3 Drop
1.2.4 Gel
1.3 Atropine Segment by Application
1.3.1 Global Atropine Sales Comparison by Application (2020-2026)
1.3.2 Gastrointestinal
1.3.3 Ophthalmology
1.3.4 Other
1.4 Atropine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Atropine Sales Growth Rate (2015-2026)
1.4.2 Global Atropine Revenue and Growth Rate (2015-2026)
1.4.3 Global Atropine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Atropine Industry Impact
1.5.1 How the Covid-19 is Affecting the Atropine Industry
1.5.1.1 Atropine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Atropine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Atropine Players to Combat Covid-19 Impact

2 Atropine Estimate and Forecast by Region
2.1 Global Atropine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Atropine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Atropine Sales Market Share by Region (2015-2020)
2.2.2 Global Atropine Revenue Market Share by Region (2015-2020)
2.3 Global Atropine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Atropine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Atropine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Atropine Estimates and Projections (2015-2026)
2.4.2 Europe Atropine Estimates and Projections (2015-2026)
2.4.3 China Atropine Estimates and Projections (2015-2026)
2.4.4 Japan Atropine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Atropine Estimates and Projections (2015-2026)
2.4.6 India Atropine Estimates and Projections (2015-2026)
3 Global Atropine Competition Landscape by Players
3.1 Global Top Atropine Players by Sales (2015-2020)
3.2 Global Top Atropine Players by Revenue (2015-2020)
3.3 Global Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atropine as of 2019)
3.4 Global Atropine Average Price by Company (2015-2020)
3.5 Manufacturers Atropine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Atropine Players (Opinion Leaders)
4 Global Atropine Market Size by Type
4.1 Global Atropine Historic Market Review by Type (2015-2020)
4.1.1 Global Atropine Sales Market Share by Type (2015-2020)
4.1.2 Global Atropine Revenue Market Share by Type (2015-2020)
4.1.3 Global Atropine Price by Type (2014-2020)
4.2 Global Atropine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Atropine Sales Forecast by Type (2021-2026)
4.2.2 Global Atropine Revenue Forecast by Type (2021-2026)
4.2.3 Global Atropine Price Forecast by Type (2021-2026)
5 Global Atropine Market Size by Application
5.1 Global Atropine Historic Market Review by Application (2015-2020)
5.1.1 Global Atropine Sales Market Share by Application (2015-2020)
5.1.2 Global Atropine Revenue Market Share by Application (2015-2020)
5.1.3 Global Atropine Price by Application (2015-2020)
5.2 Global Atropine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Atropine Sales Forecast by Application (2021-2026)
5.2.2 Global Atropine Revenue Forecast by Application (2021-2026)
5.2.3 Global Atropine Price Forecast by Application (2021-2026)

3 North America Atropine Market Facts & Figures
3.2 North America Atropine Sales Market Share by Company (2015-2020)
3.3 North America Atropine Sales Market Share by Type (2015-2020)
3.4 North America Atropine Sales Market Share by Application (2015-2020)

4 Europe Atropine Market Facts & Figures
4.2 Europe Atropine Sales Market Share by Company (2015-2020)
4.3 Europe Atropine Sales Market Share by Type (2015-2020)
4.4 Europe Atropine Sales Market Share by Application (2015-2020)

5 China Atropine Market Facts & Figures
5.2 China Atropine Sales Market Share by Company (2015-2020)
5.3 China Atropine Sales Market Share by Type (2015-2020)
5.4 China Atropine Sales Market Share by Application (2015-2020)

6 Japan Atropine Market Facts & Figures
6.2 Japan Atropine Sales Market Share by Company (2015-2020)
6.3 Japan Atropine Sales Market Share by Type (2015-2020)
6.4 Japan Atropine Sales Market Share by Application (2015-2020)

7 Southeast Asia Atropine Market Facts & Figures
7.2 Southeast Asia Atropine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Atropine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Atropine Sales Market Share by Application (2015-2020)

8 India Atropine Market Facts & Figures
8.2 India Atropine Sales Market Share by Company (2015-2020)
8.3 India Atropine Sales Market Share by Type (2015-2020)
8.4 India Atropine Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Atropine Business
12.1 C²PHARMA
12.1.1 C²PHARMA Atropine Corporation Information
12.1.2 C²PHARMA Atropine Business Overview and Total Revenue
12.1.3 C²PHARMA Atropine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 C²PHARMA Atropine Products Offered
12.1.5 C²PHARMA Recent Development
12.2 RESONANCE LABORATORIES
12.2.1 RESONANCE LABORATORIES Atropine Corporation Information
12.2.2 RESONANCE LABORATORIES Atropine Business Overview and Total Revenue
12.2.3 RESONANCE LABORATORIES Atropine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 RESONANCE LABORATORIES Atropine Products Offered
12.2.5 RESONANCE LABORATORIES Recent Development
12.3 ROLABO OUTSOURCING
12.3.1 ROLABO OUTSOURCING Atropine Corporation Information
12.3.2 ROLABO OUTSOURCING Atropine Business Overview and Total Revenue
12.3.3 ROLABO OUTSOURCING Atropine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 ROLABO OUTSOURCING Atropine Products Offered
12.3.5 ROLABO OUTSOURCING Recent Development
12.4 Minsheng
12.4.1 Minsheng Atropine Corporation Information
12.4.2 Minsheng Atropine Business Overview and Total Revenue
12.4.3 Minsheng Atropine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Minsheng Atropine Products Offered
12.4.5 Minsheng Recent Development
12.5 CR Double-Crane
12.5.1 CR Double-Crane Atropine Corporation Information
12.5.2 CR Double-Crane Atropine Business Overview and Total Revenue
12.5.3 CR Double-Crane Atropine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 CR Double-Crane Atropine Products Offered
12.5.5 CR Double-Crane Recent Development
12.6 HENAN PURUI
12.6.1 HENAN PURUI Atropine Corporation Information
12.6.2 HENAN PURUI Atropine Business Overview and Total Revenue
12.6.3 HENAN PURUI Atropine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 HENAN PURUI Atropine Products Offered
12.6.5 HENAN PURUI Recent Development
12.7 Albany Molecular Research
12.7.1 Albany Molecular Research Atropine Corporation Information
12.7.2 Albany Molecular Research Atropine Business Overview and Total Revenue
12.7.3 Albany Molecular Research Atropine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Albany Molecular Research Atropine Products Offered
12.7.5 Albany Molecular Research Recent Development
12.8 Alchem International
12.8.1 Alchem International Atropine Corporation Information
12.8.2 Alchem International Atropine Business Overview and Total Revenue
12.8.3 Alchem International Atropine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Alchem International Atropine Products Offered
12.8.5 Alchem International Recent Development
12.9 SAURAV CHEMICALS
12.9.1 SAURAV CHEMICALS Atropine Corporation Information
12.9.2 SAURAV CHEMICALS Atropine Business Overview and Total Revenue
12.9.3 SAURAV CHEMICALS Atropine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 SAURAV CHEMICALS Atropine Products Offered
12.9.5 SAURAV CHEMICALS Recent Development
12.10 Katsura Chemical
12.10.1 Katsura Chemical Atropine Corporation Information
12.10.2 Katsura Chemical Atropine Business Overview and Total Revenue
12.10.3 Katsura Chemical Atropine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Katsura Chemical Atropine Products Offered
12.10.5 Katsura Chemical Recent Development
12.11 Hangzhou Vega
12.11.1 Hangzhou Vega Atropine Corporation Information
12.11.2 Hangzhou Vega Atropine Business Overview and Total Revenue
12.11.3 Hangzhou Vega Atropine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hangzhou Vega Atropine Products Offered
12.11.5 Hangzhou Vega Recent Development
12.12 Wuhan senwayer century
12.12.1 Wuhan senwayer century Atropine Corporation Information
12.12.2 Wuhan senwayer century Atropine Business Overview and Total Revenue
12.12.3 Wuhan senwayer century Atropine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Wuhan senwayer century Atropine Products Offered
12.12.5 Wuhan senwayer century Recent Development

13 Atropine Manufacturing Cost Analysis
13.1 Atropine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Atropine
13.4 Atropine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Atropine Distributors List
14.3 Atropine Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Atropine Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Atropine Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Atropine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Atropine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Atropine Players to Combat Covid-19 Impact
Table 8. Global Market Atropine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Atropine Sales (MT) by Region (2015-2020)
Table 10. Global Atropine Sales Market Share by Region (2015-2020)
Table 11. Global Atropine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Atropine Revenue Share by Region (2015-2020)
Table 13. Global Atropine Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Atropine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Atropine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Atropine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Atropine (MT) of Key Companies (2015-2020)
Table 18. Global Atropine Sales Share by Company (2015-2020)
Table 19. Global Atropine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Atropine Revenue Share by Company (2015-2020)
Table 21. Global Atropine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atropine as of 2019)
Table 22. Global Atropine Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Atropine Manufacturing Sites and Area Served
Table 24. Manufacturers Atropine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Atropine Players
Table 27. Global Atropine Sales (MT) by Type (2015-2020)
Table 28. Global Atropine Sales Share by Type (2015-2020)
Table 29. Global Atropine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Atropine Price (MT) by Type (2015-2020)
Table 31. Global Atropine Sales Share by Type (2021-2026)
Table 32. Global Atropine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Atropine Revenue Share by Type (2021-2026)
Table 34. Global Atropine Price (MT) by Type (2021-2026)
Table 35. Global Atropine Sales (MT) by Application (2015-2020)
Table 36. Global Atropine Sales Share by Application (2015-2020)
Table 37. Global Atropine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Atropine Price (MT) by Application (2015-2020)
Table 39. Global Atropine Sales (MT) by Application (2021-2026)
Table 40. Global Atropine Sales Share by Application (2021-2026)
Table 41. Global Atropine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Atropine Revenue Share by Application (2021-2026)
Table 43. Global Atropine Price (MT) by Application (2021-2026)
Table 44. United States Atropine Sales (MT) by Company (2015-2020)
Table 45. United States Atropine Sales Market Share by Company (2015-2020)
Table 46. United States Atropine Sales (MT) by Type (2015-2020)
Table 47. United States Atropine Sales Market Share by Type (2015-2020)
Table 48. United States Atropine Sales (MT) by Application (2015-2020)
Table 49. United States Atropine Sales Market Share by Application (2015-2020)
Table 50. Europe Atropine Sales (MT) by Company (2015-2020)
Table 51. Europe Atropine Sales Market Share by Company (2015-2020)
Table 52. Europe Atropine Sales (MT) by Type (2015-2020)
Table 53. Europe Atropine Sales Market Share by Type (2015-2020)
Table 54. Europe Atropine Sales (MT) by Application (2015-2020)
Table 55. Europe Atropine Sales Market Share by Type (2015-2020)
Table 56. China Atropine Sales (MT) by Company (2015-2020)
Table 57. China Atropine Sales Market Share by Company (2015-2020)
Table 58. China Atropine Sales (MT) by Type (2015-2020)
Table 59. China Atropine Sales Market Share by Type (2015-2020)
Table 60. China Atropine Sales (MT) by Application (2015-2020)
Table 61. China Atropine Sales Market Share by Application (2015-2020)
Table 62. Japan Atropine Sales (MT) by Company (2015-2020)
Table 63. Japan Atropine Sales Market Share by Company (2015-2020)
Table 64. Japan Atropine Sales (MT) by Type (2015-2020)
Table 65. Japan Atropine Sales Market Share by Type (2015-2020)
Table 66. Japan Atropine Sales (MT) by Application (2015-2020)
Table 67. Japan Atropine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Atropine Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Atropine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Atropine Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Atropine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Atropine Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Atropine Sales Market Share by Application (2015-2020)
Table 74. India Atropine Sales (MT) by Company (2015-2020)
Table 75. India Atropine Sales Market Share by Company (2015-2020)
Table 76. India Atropine Sales (MT) by Type (2015-2020)
Table 77. India Atropine Sales Market Share by Type (2015-2020)
Table 78. India Atropine Sales (MT) by Application (2015-2020)
Table 79. India Atropine Sales Market Share by Application (2015-2020)
Table 80. C²PHARMA Corporation Information
Table 81. C²PHARMA Description and Business Overview
Table 82. C²PHARMA Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. C²PHARMA Atropine Product
Table 84. C²PHARMA Recent Development
Table 85. RESONANCE LABORATORIES Corporation Information
Table 86. RESONANCE LABORATORIES Description and Business Overview
Table 87. RESONANCE LABORATORIES Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. RESONANCE LABORATORIES Atropine Product
Table 89. RESONANCE LABORATORIES Recent Development
Table 90. ROLABO OUTSOURCING Corporation Information
Table 91. ROLABO OUTSOURCING Description and Business Overview
Table 92. ROLABO OUTSOURCING Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. ROLABO OUTSOURCING Atropine Product
Table 94. ROLABO OUTSOURCING Recent Development
Table 95. Minsheng Corporation Information
Table 96. Minsheng Description and Business Overview
Table 97. Minsheng Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Minsheng Atropine Product
Table 99. Minsheng Recent Development
Table 100. CR Double-Crane Corporation Information
Table 101. CR Double-Crane Description and Business Overview
Table 102. CR Double-Crane Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. CR Double-Crane Atropine Product
Table 104. CR Double-Crane Recent Development
Table 105. HENAN PURUI Corporation Information
Table 106. HENAN PURUI Description and Business Overview
Table 107. HENAN PURUI Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. HENAN PURUI Atropine Product
Table 109. HENAN PURUI Recent Development
Table 110. Albany Molecular Research Corporation Information
Table 111. Albany Molecular Research Description and Business Overview
Table 112. Albany Molecular Research Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Albany Molecular Research Atropine Product
Table 114. Albany Molecular Research Recent Development
Table 115. Alchem International Corporation Information
Table 116. Alchem International Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Alchem International Description and Business Overview
Table 118. Alchem International Atropine Product
Table 119. Alchem International Recent Development
Table 120. SAURAV CHEMICALS Corporation Information
Table 121. SAURAV CHEMICALS Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. SAURAV CHEMICALS Description and Business Overview
Table 123. SAURAV CHEMICALS Atropine Product
Table 124. SAURAV CHEMICALS Recent Development
Table 125. Katsura Chemical Corporation Information
Table 126. Katsura Chemical Description and Business Overview
Table 127. Katsura Chemical Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Katsura Chemical Atropine Product
Table 129. Katsura Chemical Recent Development
Table 130. Hangzhou Vega Corporation Information
Table 131. Hangzhou Vega Description and Business Overview
Table 132. Hangzhou Vega Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Hangzhou Vega Atropine Product
Table 134. Hangzhou Vega Recent Development
Table . Wuhan senwayer century Corporation Information
Table . Wuhan senwayer century Description and Business Overview
Table . Wuhan senwayer century Atropine Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Wuhan senwayer century Atropine Product
Table . Wuhan senwayer century Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Atropine Distributors List
Table 143. Atropine Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Atropine Product Picture
Figure 2. Global Atropine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Atropine Market Share by Application in 2020 & 2026
Figure 6. Gastrointestinal Examples
Figure 7. Ophthalmology Examples
Figure 8. Other Examples
Figure 9. Global Atropine Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Atropine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Atropine Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Atropine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Atropine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Atropine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Atropine Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Atropine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Atropine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Atropine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Atropine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Atropine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Atropine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Atropine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Atropine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Atropine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Atropine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Atropine Players Market Share by Revenue in Atropine 2015 & 2019
Figure 27. Atropine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Atropine Revenue Share by Type (2015-2020)
Figure 29. Global Atropine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Atropine Revenue Share by Application (2015-2020)
Figure 31. Global Atropine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Atropine Sales Market Share by Type in 2019
Figure 33. United States Atropine Sales Market Share by Type in 2019
Figure 34. Europe Atropine Sales Market Share by Company in 2019
Figure 35. Europe Atropine Sales Market Share by Type in 2019
Figure 36. Europe Atropine Sales Market Share by Application in 2019
Figure 37. China Atropine Sales Market Share by Company in 2019
Figure 38. China Atropine Sales Market Share by Type in 2019
Figure 39. China Atropine Sales Market Share by Application in 2019
Figure 40. Japan Atropine Sales Market Share by Company in 2019
Figure 41. Japan Atropine Sales Market Share by Type in 2019
Figure 42. Japan Atropine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Atropine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Atropine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Atropine Sales Market Share by Application in 2019
Figure 46. India Atropine Sales Market Share by Company in 2019
Figure 47. India Atropine Sales Market Share by Type in 2019
Figure 48. India Atropine Sales Market Share by Application in 2019
Figure 49. C²PHARMA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. RESONANCE LABORATORIES Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. ROLABO OUTSOURCING Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Minsheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. CR Double-Crane Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. HENAN PURUI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Albany Molecular Research Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Alchem International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. SAURAV CHEMICALS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Katsura Chemical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Hangzhou Vega Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Wuhan senwayer century Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Atropine
Figure 63. Manufacturing Process Analysis of Atropine
Figure 64. Atropine Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed